Trulicity 4.5 mg/.5mL
Dulaglutide · INJECTION, SOLUTION · Eli Lilly and Company
No Recall History
Plain English
Trulicity is a injection, solution containing dulaglutide at 4.5 mg/.5mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Trulicity
- Generic Name
- Dulaglutide
- NDC Code (Product)
0002-3182- Manufacturer
- Eli Lilly and Company
- Strength
- 4.5 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125469
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 09/03/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
nausea10,199 reports
injection site pain9,872 reports
blood glucose increased9,831 reports
diarrhoea5,948 reports
vomiting5,608 reports
incorrect dose administered5,535 reports
inappropriate schedule of product administration3,831 reports
drug ineffective3,602 reports
weight decreased3,390 reports
decreased appetite3,227 reports
Frequently Asked Questions
What is Trulicity used for?
Trulicity contains Dulaglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Trulicity a controlled substance?
Trulicity is not classified as a controlled substance by the DEA.
What is the generic name for Trulicity?
The generic name for Trulicity is Dulaglutide. There are 4 other brand versions of Dulaglutide.
What is the NDC code for Trulicity 4.5 mg/.5mL?
The NDC (National Drug Code) for Trulicity 4.5 mg/.5mL is 0002-3182, listed by Eli Lilly and Company.